BioSpace News Archive

Drug Development

Ablynx: Results From the Phase III Hercules Study of Caplacizumab for the Treatment of Acquired TTP Selected For Presentation in the Late-Breaking Abstracts Session at the 2017 ASH Annual Meeting

Positive topline results from the Phase III HERCULES study, meeting primary and two key secondary endpoints, were announced on 2 October 2017.

November 21, 2017

·

5 min read

Business

Invuity Appoints Scott Flora to Board of Directors

Mr. Flora, who brings more than 30 years of medical device leadership experience, has served as a senior advisor for Invuity since February 2015.

November 21, 2017

·

2 min read

Drug Development

Data from Phase III ALCYONE Study of Daratumumab Accepted for Oral Presentation at Annual Meeting of the American Society of Hematology

The abstract is published online on the ASH website: www.hematology.org.

November 21, 2017

·

7 min read

Lundbeck Increases Its Share Capital by 116,330 Shares (0.0585 % of Outstanding Shares) as a Result of Exercise of Employee Warrants

The increase is effected without any preemption rights for the existing shareholders of the company or others.

November 21, 2017

·

3 min read

Biotech Bay

Zomedica Pharmaceuticals Corp. Registration Statement Declared Effective by U.S. Securities and Exchange Commission

The Company will retain its listing on the TSX Venture Exchange (TSX-V).

November 21, 2017

·

4 min read

Drug Development

Axim Biotechnologies Announces Phase IIa Trial Results Validating its Proprietary Cannabinoid Delivery Method for Treatment of Irritable Bowel Syndrome (IBS)

Participants of AXIM Biotech’s Phase IIa trial experienced a decrease in their pain score and improvement in their quality of life score, highlighting the efficacy of AXIM’s patented CBD chewing gum delivery method, allowing for AXIM to move forward with further trials with predetermined dosing.

November 21, 2017

·

4 min read

Noxxon Issues Third Tranche of Odirnane Bonds

NOXXON Pharma announced today that it has issued the third tranche of the ODIRNANE bonds.

November 21, 2017

·

2 min read

Biotech Bay

Bio-Rad to Webcast Investor Day 2017

The presentations and webcast will begin at 9 AM (ET).

November 21, 2017

·

1 min read

Drug Development

Exelixis Announces Phase III CELESTIAL Trial Results of Cabozantinib in Previously Treated Advanced Hepatocellular Carcinoma to be Presented at 2018 Gastrointestinal Cancers Symposium

Exelixis to submit supplemental New Drug Application to the FDA in the first quarter of 2018.

November 21, 2017

·

13 min read

Pharm Country

Fujifilm Exhibits its Latest Innovations in Digital Radiography at RSNA 2017

The all new mini-digital X-ray system combines the high sensitivity of Fujifilm’s D-EVO II detectors and its refined image processing advancements to generate high resolution images with low patient dose.

November 21, 2017

·

4 min read